Abstract: Endothelial IK Ca and/or SK Ca channels play an important role in the control of vascular tone by participating in endothelium-dependent relaxation. Whether b-AR antagonists, mainly used in hypertension, affect endothelial K Ca channel function is unknown. In this study, we examined the effect of the b2-AR antagonist and inverse agonist ICI 118,551 on the IK Ca / SK Ca channel activity by assessing functional relaxation responses to several agonists that stimulate these channels. Mesenteric arterial rings isolated from male Sprague Dawley mounted to organ baths. Acetylcholine elicited IK Ca -and SK Ca -mediated relaxations that were abolished by TRAM-34 and apamin, respectively. ICI 118,551, which did not dilate the arteries per se, increased the IK Ca -mediated relaxations, whereas SK Ca -mediated relaxations remained unaltered. Same potentiating effect was also detected on the IK Ca -mediated relaxations to carbachol and A23187, but not to NS309. Neither acetylcholine-induced nitric oxidemediated relaxations nor SNP relaxations changed with ICI 118,551. The PKA inhibitor KT-5720, the selective b2-AR agonist salbutamol, the selective b2-AR antagonist butoxamine, the non-selective b-AR antagonist propranolol, and the inverse agonists carvedilol or nadolol failed to affect the IK Ca -mediated relaxations. ICI 118,551-induced increase was not reversed by salbutamol or propranolol as well. Besides, low potassium-induced relaxations in endothelium-removed arteries remained the same in the presence of ICI 118,551. These data demonstrate a previously unrecognized action of ICI 118,551, the ability to potentiate endothelial IK Ca channel-mediated vasodilation, through a mechanism independent of b2-AR antagonistic or inverse agonistic action. Instead, the enhancement of acetylcholine relaxation seems likely to occur by a mechanism secondary to endothelial calcium increase.
Stimulation of G-protein-coupled receptors in the endothelium increases cytosolic calcium level and induces hyperpolarization of endothelial cell membrane due to activation of intermediate-and/or small-conductance calcium-activated potassium channels (IK Ca and/or SK Ca , respectively). This hyperpolarization is transferred to underlying smooth muscle either directly via heterocellular gap junctions [1] or by means of potassium ions accumulated in myoendothelial space following activation of endothelial K Ca channels [2] , which lead to hyperpolarization and subsequent relaxation of the smooth muscle. This phenomenon is known as endothelium-dependent hyperpolarization (EDH) [3] . In resistance arteries regulating blood pressure and flow to the organs, EDH predominantly contributes to smooth muscle relaxation compared with other endothelium-derived relaxing factors such as nitric oxide (NO) and prostacyclin (PGI 2 ), and its role in vasorelaxation increases when NO bioavailability is decreased under certain vascular pathologies. The role of EDH in the regulation of vascular tone is strongly supported by the studies showing a marked increase in blood pressure in IK Ca -deficient mice [4] or in spontaneously hypertensive rats lacking EDH-mediated relaxations [5] . Therefore, it could be hypothesized that vascular signalling pathways modulating IK Ca and/or SK Ca channel activity might affect the contribution of EDH to vascular tone and blood pressure regulation.
b-Adrenoceptors (b-ARs) are the members of the Ga s -, Ga i/o -or Ga q -protein-coupled receptor (GPCR) family and are partly responsible for the effects of sympathetic mediators adrenaline and noradrenaline on the cardiovascular system. b1-, b2-and atypical b-ARs in rat main mesenteric arteries [6] , and b1-ARs in rat mesenteric resistance arteries have been identified [7] . In these arteries, the non-selective b-AR agonist isoprenaline has been suggested to inhibit EDH-mediated relaxation via phosphorylation of endothelial IK Ca channels by protein kinase A (PKA) [8] . In tracheal myocytes, however, isoprenaline stimulates big-conductance calcium-activated potassium channels (BK Ca ) via membrane-delimited action of Ga s protein, which is independent of cyclic adenosine 3 0 5 0 monophosphate (cAMP)-dependent phosphorylation [9] . Moreover, in long-term isoprenaline-treated mice, vascular contractility is increased in aortic rings [10] . Therefore, it would be reasonable to examine whether the b-AR blockers, which are mainly used in the treatment of hypertension, affect the EDHtype relaxation in vasculature. Indeed, the third generation of b-AR blockers, besides their cardiac effects, are known to improve endothelial function via some peripheral effects. Nebivolol, for example, stimulates endothelial NO release in coronary microvessels [11] , whereas carvedilol increases its bioavailability [12] . The selective b2-AR antagonist and Author for correspondence: Serdar Uma, Faculty of Pharmacy, Department of Pharmacology, Hacettepe University, 06100, Sihhiye, Ankara, Turkey (e-mail seuma@hacettepe.edu.tr).
inverse agonist ICI 118,551 shows promising results in the treatment of pulmonary hypertension by stimulating NO pathway in pulmonary arterial vasculature [13] . However, to what extent these b-AR blockers affect EDH-type vasorelaxation under in vitro organ bath experimental conditions is unknown.
In this respect, we particularly aimed to study the effects of ICI 118,551 on acetylcholine-induced EDH-type relaxations as this agent has previously been shown to increase IK Ca channel currents in human mast cells [14] . Here, we report that ICI 118,551 potentiates EDH-type vasorelaxation by facilitating the activity of IK Ca channels in the endothelium of rat main mesenteric artery.
Materials and Methods
All the procedures of experiments were conducted in accordance with the approval of the Animal Ethics Committee of Hacettepe University (No: 2013/39-03).
Male Wistar rats (250-350 g) were used in the experiments. After carbon dioxide anaesthesia, the animals were killed by bleeding from the carotid artery. Main branch of the superior mesenteric artery was rapidly removed and placed into a petri dish containing Krebs-Henseleit solution (KHS) at 4°C. The vessels were cleaned of fat and connective tissues and cut into rings of 2 mm in length. Where indicated, the endothelium was destroyed by rubbing intimal surface of rings with a stainless steel wire of appropriate size. Removal of the endothelium was confirmed by lack of relaxation to 10 lM acetylcholine in the rings pre-contracted with phenylephrine (0.3 lM). The rings were suspended in 5 ml organ baths containing KHS gassed with 95% O 2 -5% CO 2 at 37°C. The tissues were connected to isometric force transducer, and changes in tension were recorded on a computer via 'MAY 95-Transducer Data Acquisition System'. Tissues were equilibrated at an optimal resting tension of 1 g for 45 min. where they were washed out in every 10 min. with freshly warmed KHS and then repeatedly exposed to 60 mM KCI until reproducible contractions were obtained before starting the experimental protocol.
The isolated rings of rat mesenteric artery were pre-contracted with 1 or 3 lM phenylephrine, which caused a response equivalent to 60-80% of the maximum tissue contraction. Acetylcholine (1 nM-10 lM) was then added to the baths cumulatively, and concentrationdependent relaxation responses were obtained. To determine the (1) IK Ca -, (2) SK Ca -and (3) NO-mediated components of acetylcholineinduced relaxation, responses were obtained in the presence of (1) L-NAME (100 lM) + indomethacin (10 lM) + apamin (50 nM), (2) L-NAME + indomethacin + TRAM-34 (1 lM) and (3) indomethacin + TRAM-34 + apamin, respectively. As the addition of L-NAME increased basal tone of the rings, concentration of phenylephrine was lowered so as to give a contraction similar in magnitude to that of the control. After a washout period, the rings were incubated with 3 lM ICI 118,551 for 30 min. and acetylcholine responses were repeated in the presence of the same blockers mentioned above. Likewise acetylcholine, relaxation responses to sodium nitroprusside (SNP) (1 nM-10 lM), the NO donor and carbachol (1 nM-10 lM), another muscarinic agonist, were also tested in the presence and absence ICI 118,551. In a group of experiments, salbutamol (10 lM), the selective b2-AR agonist, butoxamine (10 lM), the selective b2-AR antagonist, and KT-5720 (1 lM), the PKA inhibitor, were used to evaluate the b-AR-mediated nature of the effect of ICI 118,551.
In another group of experiments, carvedilol (0.3 lM) and nadolol (10 lM), which are b-AR blockers showing inverse agonistic action, and propranolol (1 lM), the non-selective b-AR blocker, were used to test whether the effects of ICI 118,551 in rat mesenteric artery were involved in its inverse agonistic mechanism. We also examined A23187 (0.03 lM), the calcium ionophore and NS309 (0.1-10 lM), the IK Ca channel opener-induced relaxations in the presence of ICI 118,551 so as to examine the sensitivity of ICI 118,551 to different agonists' IK Camediated relaxations. In a separate group of experiments, relaxation responses to low level of potassium (a candidate ion for EDH-mediated responses) were studied before and after incubation with ICI 118,551 to assess the cellular nature of ICI 118,551's effect.
Sixty millimolar KCI solution was prepared by substitution of KCI with equimolar NaCI. Acetylcholine hydrochloride, apamin, A23187, butoxamine, phenylephrine hydrochloride, propranolol, salbutamol, TRAM-34, carvedilol, nadolol, ICI 118,551, indomethacin, SNP, NS309 and KT-5720 were purchased from Sigma Chemical Co. (St. Luis, MO, USA). Indomethacin was prepared in distilled water containing 0.7% (wt/vol) Na 2 CO 3 . Stock solutions of A23187 were dissolved in dimethyl sulfoxide (DMSO). Further dilutions and all of the other drug solutions were prepared in distilled water. None of the solvents did affect the arterial tone at their final volumes.
Responses to agonists were expressed as the percentage of pre-contraction induced by phenylephrine as the basal tone did not change after any drug pre-treatment in the mesenteric arterial rings. Data were expressed as means AE S.E.M of n replicates. The statistical comparisons between two concentration-response curves were made using two-tailed Student's t-test for paired data. GraphPad Prism ver 6.0 (GraphPad Software, Inc., San Diego, California, USA) was used for statistical analysis program. p value <0.05 was considered as statistically significant. Efficacy of agonists was expressed as E max and the pD 2 values were calculated for agonist potency, which is the negative logarithm of molar concentration required to produce 50% of the maximum response (EC 50 ).
Results
In the phenylephrine-pre-contracted rings, acetylcholine (1 nM-10 lM) elicited a concentration-dependent relaxation with the pD 2 value of 7.68 AE 0.04 (n = 7). After inhibition of endothelial NO synthase, cyclooxygenase and SK Ca channels with L-NAME (100 lM), indomethacin (10 lM) and apamin (50 nM), respectively, the remaining part of acetylcholineinduced relaxation was due to the activation of endothelial IK Ca channels, which was blocked by TRAM-34 (1 lM). Incubation of the rings with ICI 118,551 (3 lM) for 30 min. did not change basal or pre-contractile tone, but it significantly enhanced the IK Ca -mediated relaxation to acetylcholine ( fig. 1A ). This enhancement was reversible. Because following washout of ICI 118,551, response to acetylcholine returned to its initial level (data not shown). ICI 118,551 augmented both efficacy and potency of acetylcholine. E max value changed from 70.4 AE 3.8% to 82.5 AE 1.7% and the pD 2 value from 6.5 AE 0.1 to 7.3 AE 0.1 (*p < 0.05) (n = 7). This increased response was significantly reduced by TRAM-34 (1 lM) indicating that the effect of ICI 118,551 was due to the opening of IK Ca channels ( fig. 1A) .
In rat mesenteric arterial rings incubated with L-NAME, indomethacin and TRAM-34, acetylcholine induced SK Camediated relaxations with an E max value of 48.75 AE 9.94% and a pD 2 value of 6.4 AE 0.08 (n = 5). ICI 118,551 (3 lM) did not alter the SK Ca -mediated relaxations, which was abolished by apamin (50 nM) ( fig. 1B ). In addition, neither acetylcholine-induced NO-mediated relaxations ( fig. 1C ) (n = 4) nor SNP-induced relaxations (n = 5) were changed in the presence of ICI 118,551 ( fig. 1D ).
We next examined the effect of selective b2-AR agonist salbutamol (10 lM) on the IK Ca -mediated relaxations of acetylcholine. In our experimental conditions, salbutamol was found ineffective in changing acetylcholine-induced IK Ca relaxations. The pD 2 value was 6.9 AE 0.1 and 6.7 AE 0.08 in the absence and presence of salbutamol (n = 8). Similar results were obtained for the non-selective b2-AR agonist isoprenaline (10 lM). The pD 2 value was 7.1 AE 0.02 and 6.94 AE 0.07 in the absence and presence of isoprenaline (n = 5). In the presence of salbutamol, ICI 118,551-enhanced IK Ca relaxations displayed a decline, which was not significantly different from the control (n = 5) ( fig. 2A) . In contrast to ICI 118,551, the b2-AR antagonist butoxamine (10 lM) was found ineffective in potentiating IK Ca -mediated relaxations to acetylcholine (n = 5) (fig. 2B ). The pD 2 value was 7.16 AE 0.27 and 6.93 AE 0.27 in the absence and presence of butoxamine (n = 5). The E max value was 82.44 AE 8.46 and 78.72 AE 8.40 in the absence and presence of butoxamine (n = 5).
We investigated the effect of the PKA inhibitor KT-5720 on the IK Ca channel function as the main downstream pathway linked to b-AR signalling is the cAMP-PKA pathway. KT-5720 (1 lM) neither affected the acetylcholine-induced IK Camediated relaxations nor prevented the potentializing effect of ICI 118,551 (n = 4) ( fig. 3) .
Other b-AR blockers known as inverse agonists, carvedilol (0.3 lM) and nadolol (10 lM), in contrast to ICI 118,551, failed to increase acetylcholine-induced IK Ca -mediated relaxations (n = 4 for both) ( fig. 4A and 4B) . Moreover, ICI 118,551-enhanced IK Ca -mediated relaxations did not reverse to control level with propranolol (1 lM), the non-selective b-AR blocker. The pD 2 value was 7.2 AE 0.07 in the presence of ICI 118,551 and 7.0 AE 0.01 in the presence of ICI 118,551 together with propranolol (n = 5) ( fig. 4C) .
We also tested the effect of ICI 118,551 on the IK Ca relaxations stimulated by different agonists so as to explore the underlying signalling pathways. Another muscarinic receptor agonist carbachol (1 nM-10 lM), likewise acetylcholine, elicited a concentration-dependent relaxation, which was shifted to the left in the presence of ICI 118,551. The pD 2 value was 6.4 AE 0.2 and 6.9 AE 0.1 in the absence and presence of ICI 118,551 (*p < 0.05) (n = 4) ( fig. 5 ). The calcium ionophore A23187 (30 nM) elicited IK Ca -mediated relaxation in the presence of L-NAME+indomethacin+apamin. ICI 118,551 potentiated this relaxation, and TRAM-34 inhibited it. The relaxation to A23187 increased from 47.81 AE 7.6% to 77.63 AE 3.6% with ICI 118,551 (*p < 0.05), and this increase returned to almost baseline level (3.81 AE 3.8%) when incubated with TRAM-34 ( ♯ p < 0.05) (n=6) ( fig. 6 ). However, the IK Ca channel opener NS309-induced relaxation was not affected from ICI 118,551. The pD 2 value was 6.03 AE 0.1 and 6.02 AE 0.4 in the absence and presence of ICI 118,551, respectively (n = 4). A small increase in potassium concentration of the extracellular medium leads to hyperpolarization and relaxation in endothelium-denuded rat mesenteric artery, as this manipulation mimics potassium efflux from the endothelium to the myoendothelial space during the EDH-associated relaxations after the activation of IK Ca and/or SK Ca channels [2] . Finally, we examined the influence of ICI 118,551 on 5 mM extracellular potassium-induced relaxations in endotheliumdenuded arteries and found that relaxations were unchanged in the presence of ICI 118,551 (n = 4) ( fig. 7) .
Discussion
In the present study, we examined the effect of b2-AR selective antagonist and inverse agonist ICI 118,551 on EDHmediated relaxations of rat main mesenteric artery. We demonstrated that ICI 118,551 shifted the IK Ca -mediated relaxation component of acetylcholine to the left by about 10-fold without affecting SK Ca -or NO-mediated relaxation components. Therefore, the current study provides evidence for the first time that ICI 118,551 potentiates the EDH-type relaxations occurring predominantly through endothelial IK Ca channels. The increased relaxations were not due to decreased pre-contractions induced by phenylephrine as they remained unchanged when incubated with ICI 118,551. However, in a previous study, ICI 118,551 has been shown to inhibit sensitivity to contractile agents in large pulmonary arteries of mice via a b2-AR-Ga i/o protein-dependent mechanism leading to the enhancement of NO production in the endothelium [13] . This effect of ICI 118,551 seems to differ between species and vascular bed under investigation because in mouse aorta the researchers failed to detect the same tonic response. Our data strongly suggest that generation and release of endothelial NO are not likely involved in the mode of action of ICI 118,551 in rat mesenteric artery, as NO-mediated relaxations to acetylcholine were unaffected by ICI 118,551. In support of this, we showed that relaxations elicited by SNP, the agent that produces vasodilation through liberation of NO from its structure, were not altered as well, suggesting that NO-cyclic guanosine 3 0 5 0 monophosphate (cGMP) pathway does not play role in the action of ICI 118,551. The leftward shift was not restricted to acetylcholine alone but was also detected in carbachol-induced relaxations, indicating that the interaction occurs at the level of muscarinic receptors and/or postreceptor downstream signalling pathway(s). The b2 adrenoceptor is a G-protein-coupled receptor that, upon activation by catecholamines, increases the intracellular second messenger cAMP level. Elevated cAMP leads to the activation of PKA, the major cAMP-binding effector protein, which subsequently phosphorylates various target proteins to induce vasodilation. However, there is a controversy in the literature about contribution of PKA to endothelium-dependent relaxations. In capacitance arteries such as aorta, PKA mediates endothelium-dependent relaxations induced by forskolin [15] or b2-AR stimulation [16] , whereas in third branches of rat mesenteric artery, the non-selective b2-AR agonist isoprenaline decreases endothelium-dependent hyperpolarization and relaxation by phosphorylating IK Ca channels via PKA [8] . The inhibitory effect of PKA on IK Ca channels has also been suggested in neuronal tissues [17] . Therefore, if an intrinsic b2-AR signalling exists, then the inhibition of PKA pathway should be expected to mimic the effects of ICI 118,551. However, according to our data, the PKA inhibitor KT-5720 did not reverse the ICI 118,551-induced potentiation, suggesting that PKA is not likely involved. Accordingly, the failure of selective b2-AR agonist salbutamol to shift the dose-response curve of acetylcholine to the right and to prevent the enhancing activity of ICI 118,551, although a small but insignificant reversal was observed, suggests that b2-ARs are not responsible for the mode of action of ICI 118,551. Yet, the concentration of ICI 118,551 used was considerably higher (approximately 100-fold) than that needed to block these receptors [18] . Moreover, the inability of butoxamine, another selective b2-AR antagonist, to augment acetylcholine relaxations, strengthens the view that ICI 118,551 exerted its effect by a mechanism independent of b2-AR antagonism.
Another protein target of adenylyl cyclase-cAMP pathway is exchange protein activated by cAMP (EPAC) [19] . In rat mesenteric artery, several subtypes of K Ca channels located both in endothelium and vascular smooth muscle have been shown to be responsible for the EPAC-mediated relaxation induced by a cAMP analogue [19] . However, we were unable to examine the effect of EPAC antagonist ESI-09 on ICI 118,551-induced enhancement of acetylcholine response as it, unexpectedly, relaxed the phenylephrine-pre-contracted arterial rings, as previously reported for rat aorta [15] .
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Of the third generation of b-AR blockers, carvedilol and nadolol are known as inverse agonists. These drugs provide additional vascular effects through increasing NO bioavailability besides their cardiac b-AR blocking actions in the treatment of hypertension [20] . On the other hand, the negative inotropy in rat atria [18] and the increase in IK Ca channel currents in quiescent human mast cells [14] , both induced by ICI 118,551, have been attributed to its inverse agonistic action, which appeared at concentrations similar to that used in the present study (1 lM). Whether the same mechanism is valid for EDH-mediated relaxations in vasculature is unknown. However, unlike ICI 118,551, both carvedilol and nadolol failed to shift the concentration-response curve of acetylcholine to the left. Although the effects of b2-AR inverse agonists are expected to be blocked by non-selective b-AR blockers [21] , propranolol did not reverse the ICI 118,551-potentiated IK Ca relaxations back to its control levels, suggesting that inverse agonism as well is not likely the mechanism in the mode of action of ICI 118,551.
b1-and b2-ARs are expressed in both endothelial and smooth muscle layers of rat mesenteric resistance arteries [22] . In these vessels, isoprenaline has been suggested to stimulate endothelial b1-ARs that subsequently lead to inhibition of acetylcholine-induced EDH-mediated relaxation through phosphorylation of IK Ca channels by PKA [8] . However, in the present work, isoprenaline did not evoke an inhibition of the IK Ca -mediated relaxations to acetylcholine, while ICI 118,551 caused potentiation. This discrepancy could be due to diverse receptor distribution throughout the branches of mesenteric vascular bed.
The calcium ionophore A23187 is an agent that stimulates calcium-dependent endothelial factors and thereby activates K Ca channels by elevating intracellular calcium via receptorindependent mechanisms [23, 24] . Our finding that ICI 118,551 potentiated the relaxation responses to both carbachol and A23187 provides evidence that the effect might be linked to a calcium-dependent downstream signalling pathway activated by muscarinic receptor stimulation. At this point, we are unable to explain why acetylcholine-induced NO release is not involved, as it is well known that an increase in endothelial calcium is an important stimulus not only for the activation of EDH-mediated pathways but also for the formation of NO. However, it has been suggested that the pathway by which agonists raise intracellular calcium might determine the nature of the endothelial product secreted [25] . In this regard, acetylcholine has been shown to resemble cyclopiazonic acid, which selectively stimulates EDH, in terms of its ability to raise intracellular calcium [26] . On the other hand, failure of ICI 118,551, per se, to induce vasodilation in phenylephrine-precontracted arteries (data not shown) and to potentiate the relaxant response to NS309, a positive gating modulator of K Ca channels, indicates that it has no direct action on IK Ca channels.
The potentiating effect of ICI 118,551 was selective to IK Ca channels although the activation of both IK Ca and SK Ca channels depends on cytosolic calcium increase in the endothelium. This selectivity might be explained by different spatial distribution of the two K Ca channels in endothelial layer. IK Ca channels are located mainly on the endothelial projections that contact with smooth muscle cells by passing internal elastic lamina while SK Ca channels are mainly distributed at interendothelial connection sites [27] . This locational diversity might enable the b-AR signalling to reach IK Ca channels more easily during agonist stimulation.
To better understand the mechanism of action of ICI 118,551, relaxant responses to small increases in extracellular potassium were evaluated in endothelium-denuded rings, because potassium efflux from IK Ca and SK Ca channels of endothelium is known to provoke relaxation of vascular smooth muscle by activating inwardly rectifying potassium channels and Na + -K + -ATPase [2] . Potassium-induced relaxations remained the same in the absence or presence of ICI 118,551, indicating that endothelium, rather than the smooth muscle, is the main target that ICI 118,551 acts on.
In conclusion, in rat mesenteric arteries, ICI 118,551 augments acetylcholine-induced vasodilation through selective activation of endothelial IK Ca channels by an unknown mechanism that is independent of its traditional b2-AR antagonistic and/or inverse agonistic property. Although the non-involvement of b2-ARs may lead to underestimation of the physiological relevance of this interaction, from a pharmacological point of view, we propose that ICI 118,551 would be of importance as a research tool in studies aiming to examine the role of vascular IK Ca channels in various pathophysiological conditions. 11th ISRA Meeting, Banff, Canada, and the abstract was published in the Journal of Vascular Research in 2014.
